Table 1 Socio-demographic characteristics of the study population.

From: Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients

 

Naïve (n = 101)

RTI-treated (n = 118)

PI/r-treated (n = 143)

p-valuea

Gender

Female n (%)

59 (28.5)

73 (35.3)

75 (36.2)

0.516

Male n (%)

42 (27.1)

45 (29.0)

68 (43.9)

Age (years), median [IQR]

38 [31–48]

44 [35–52]

41 [33–47]

0.031

CD4 (cells/μl), median [IQR]

231 [60–340]

169 [58–393]

167 [61–362]

0.760

Viral load (Log10/copies/mL), median [IQR]

5.61 [5.4–6.7]

5.3 [4.7–5.7]

5.1 [4.3–5.6]

 < 0.0001

ART regimen n (%)

2NRTIs + EFV

69 (58.4)

 

2NRTIs + NVP

49 (41.5)

 

2 NRTIs + LPV/r

94 (65.7)

 

2 NRTIs + ATV/r

47 (32.9)

 

2 NRTIs + IDV/r

2 (1.4)

 
  1. IQR: Interquartile range; NRTIs: Nucleoside reverse transcriptase inhibitors; EFV: Efavirenz; NVP: Nevirapine; LPV/r: Lopinavir; ATV/r: Atazanavir; IDV/r: Indinavir; PI/r: ritonavir boosted protease inhibitors; RTI: Reverse transcriptase inhibitors.
  2. aChi-squared of independence test was used to estimate the potential differences.